Patent details
301224
Product Name:
Combinatie van foslevodopa en foscarbidopa, elk desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301224
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3209302
Status:
SPC granted but not yet in force
Application number:
301224
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
1
Marketing Authorization Number:
141371
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/08/2022
Marketing Authorization Country:
Austria (AT)
2
Marketing Authorization Number:
RVG128752
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2022
Marketing Authorization Country:
Netherlands (NL)
Dates
Filing date:
24/03/2023
First Marketing Authorization date:
26/08/2022
Grant date:
16/08/2023
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/03/2023
SPC/SPC Extension Expiration Date:
25/08/2037
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
24/03/2023
Name:
AbbVie Inc.
Address:
1 North Waukegan Road, NORTH CHICAGO, IL 60064, United States of America (US)
Agent
Name:
ir. F.A. Geurts c.s.
From:
24/03/2023
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
34/23
Publication date:
23/08/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
13/23
Publication date:
29/03/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/10/2035
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
16/08/2023
Outgoing Correspondence
Decision grant
1
PDF
/1/2/1/3/6/0800863121/docs/301224_12_561659l504a.pdf
16/08/2023
Certificate
Certificate
1
PDF
/1/2/1/3/6/0800863121/docs/301224_13_spcmedcertificate20230816091551178.pdf
09/08/2023
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/1/2/1/3/6/0800863121/docs/301224_11_incomingcorrespondencepaper20230809021538162.pdf
26/07/2023
Outgoing Correspondence
Letter to applicant
2
PDF
/1/2/1/3/6/0800863121/docs/301224_10_557623l173.pdf
27/03/2023
Outgoing Correspondence
Confirmation receipt request
1
PDF
/1/2/1/3/6/0800863121/docs/301224_9_537907l174.pdf
24/03/2023
Application Form
First filed application form
4
PDF
/1/2/1/3/6/0800863121/docs/301224_0_applicationform20230327090150839.pdf
24/03/2023
SPC Documents
Marketing Authorization SPC
3
PDF
/1/2/1/3/6/0800863121/docs/301224_1_supplprotectioncertificate20230327090751907.pdf
24/03/2023
SPC Documents
Annex SPC
3
PDF
/1/2/1/3/6/0800863121/docs/301224_2_supplprotectioncertificate20230327090653431.pdf
24/03/2023
SPC Documents
Marketing Authorization SPC
2
PDF
/1/2/1/3/6/0800863121/docs/301224_3_supplprotectioncertificate20230327090844054.pdf
24/03/2023
SPC Documents
Annex SPC
2
PDF
/1/2/1/3/6/0800863121/docs/301224_4_supplprotectioncertificate20230327093806142.pdf
24/03/2023
SPC Documents
Annex SPC
10
PDF
/1/2/1/3/6/0800863121/docs/301224_5_supplprotectioncertificate20230327093744632.pdf
24/03/2023
SPC Documents
Annex SPC
2
PDF
/1/2/1/3/6/0800863121/docs/301224_6_supplprotectioncertificate20230327093928387.pdf
24/03/2023
SPC Documents
Summary of the characteristics of the product
21
PDF
/1/2/1/3/6/0800863121/docs/301224_7_supplprotectioncertificate20230327094031756.pdf
24/03/2023
SPC Documents
Annex SPC
1
PDF
/1/2/1/3/6/0800863121/docs/301224_8_supplprotectioncertificate20230327094147097.pdf